Latest News

Presented by Michael S. Saag, MD, Melanie A. Thompson, MD, and Roger J. Bedimo, MD, MS, this webinar will describe the core principles of HIV management, including pathogenesis of HIV infection and mechanisms of action of antiretroviral drugs, as well as initiating antiretroviral therapy and primary care for people who are newly diagnosed with HIV. This […]

The primary results of the REPRIEVE Trial have been published and show that the statin drug pitavastatin calcium lowers the risk of heart disease in people with HIV by 35%. The results of this important large, randomized trial will have a substantial impact on the health of people with HIV.  Congratulations to the study team, led by IAS-USA Core Faculty member Dr Steven Grinspoon, for bringing these important results to the HIV community. The details and results [...]

Jeanne M. Marrazzo, MD, has been appointed director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Dr Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham, as well as a former member of the IAS-USA board of directors and speaker for the IAS-USA and [...]

Presented by Paul E. Sax, MD, and moderated by Marina Klein, MD, MS, this webinar will provide a comprehensive overview of the latest developments in HIV research presented at the 2023 International AIDS Conference (The 12th International AIDS Society Conference on HIV Science) held in Brisbane, Australia from July 23 to July 26, 2023. For […]

Presented by Annie Luetkemeyer, MD, and moderated by Connie Celum, MD, this webinar reviews the current recommendations by the Centers for Disease Control and Prevention (CDC) for the use of doxycycline postexposure prophylaxis (doxy-PEP) for the prevention of sexually transmitted infections (STIs). Topics will include the criteria to determine appropriate candidates for doxy-PEP therapy, strategies […]

We are saddened by the news of Dr Albert Anderson’s passing on July 25, 2023. Apart from his many accomplishments in the field of neurology, he was an important contributor to IAS-USA activities, including authorship on Topics in Antiviral Medicine issues summarizing new data from the annual Conference on Retroviruses and Opportunistic Infections (CROI). Our field has [...]

Save the Date! We are pleased to announce the upcoming IAS–USA virtual symposium on the Implementation of Long-Acting Drugs for Treatment and Prevention of HIV, scheduled for Monday, November 13. Chaired by renowned experts Raphael J. Landovitz, MD, MSc (University of California Los Angeles), and Susan Swindells, MBBS (University of Nebraska Medical Center), this half-day course will […]

CME credit is now available for the June/July 2023 issue of Topics in Antiviral Medicine™ (TAM) at https://www.iasusa.org/tam/june-july-2023/. This issue offers up to 4.25 CME credits. This issue contains 4 review articles on new data presented at the 2023 Conference on Retroviruses and Opportunistic Infections. Topics include the latest in basic science research in HIV, metabolic and neuropsychiatric complications in patients […]

To comply with the MATE Act, all registered practitioners are now required by the Drug Enforcement Administration (DEA) to complete an 8-hour training session aimed at educating them on how to treat and manage patients who are dealing with substance use disorders. The IAS–USA is excited to support clinicians in meeting these new requirements with a […]

Registration for the 2023 RWHAP CLINICAL CONFERENCE is now open! The conference will be held in person from Sunday, December 3, to Tuesday, December 5, at the Hilton Portland Downtown in Portland, Oregon. Serving as co-chairs this year are Roger J. Bedimo, MD, MS, of the University of Texas Southwestern Medical Center at Dallas, Texas; Laura [...]